ELISA NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Biodesix Prices $72M IPO Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share. McGill Spinout Nplex Launching Highly Multiplexed ELISA System Next Year Premium The firm uses a miniaturized, bead-based-ELISA format to multiplex hundreds to thousands of immunoassays rapidly and without antibody cross-reactivity. Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay Premium The San Francisco-based startup believes that its QiSant assay could help guide the use of immunosuppressive drugs and other therapies to prevent kidney transplant rejection. Startup Nephrosant Aims to Launch Noninvasive Kidney Transplantation Test by Early 2020 Premium The UCSF spinout aims to develop noninvasive tests to detect kidney injury for the transplantation field and to diagnose and monitor chronic disease. Mar 22, 2019 Spontaneous Preterm Birth Clues Identified in Cervicovaginal Microbiome Mar 11, 2019 Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent Oct 9, 2018 10,000 Immunomes Project Establishes Initial Baseline for Healthy Immune System Nov 9, 2017 Biovica Eyes 2020 Commercial Launch for DiviTum Metastatic Breast Cancer Assay Premium Apr 25, 2017 LabCorp Q1 Revenues Grow 5 Percent Apr 11, 2017 MilliporeSigma Developing New Instrument for Single-Molecule Biomarker Detection Premium Jun 6, 2016 U of Ottawa Proteomics Study ID's Crohn's Disease, Ulcerative Colitis in IBD Patients Premium Oct 2, 2015 UCSF Team Using NHLBI Grant to ID Lung Disease Protein Markers in Premature Infants Premium Aug 7, 2015 New Study Describes Development of Simoa Assays for C. Diff Toxin Detection Premium Apr 3, 2015 PhasiQ Awarded NSF Grant to Develop Multiplex Protein Biomarker Test for DVT Premium Feb 20, 2015 Researchers Develop Simoa-based Assay for Dengue Fever Host Immune Response Aug 21, 2014 Study Demonstrates Molecular Testing Superior to ELISA for Diagnosing Invasive Aspergillosis Premium Mar 20, 2013 Nuclea, Wilex Partner to Offer Breast Cancer Testing Service Apr 18, 2012 Serametrix, Penn State Working to Personalize Immunotherapy for Pediatric Brain Cancer Premium Dec 7, 2011 OncoHealth Takes on HPV Testing Market with Protein-Based Assay Sep 28, 2011 New VEGF Biomarker Data Illustrates Complexities of Personalizing Anti-Angiogenic Drugs Premium Jan 26, 2011 In FDA Appeal, Genentech Proposes Biomarker Strategy to Keep Avastin Available for Best Responders Premium Jan 14, 2011 FDA Official Offers Agency's Take on Protein IVDMIA Mock 510(k) Submissions Premium Jun 23, 2009 India's Super Religare Laboratories Launches Array-Based Food Intolerance Testing Service Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.